Global Anxiolytics Market, By Indication (Anxiety, Insomnia, Panic Disorder, Others), Drug Class (Benzodiazepines, Azapirones, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029
Anxiolytics Market Analysis and Size
The anxiolytics market is expected to witness significant growth during the forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market. The growth of anxiolytics market enhanced by the growing cases of mental illness and rise in the research and development activities which many pharmaceuticals’ companies conduct. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the anxiolytics market in the forecast period 2022-2029. The expected CAGR of global anxiolytics market is tend to be around 4.5% in the mentioned forecast period. The market was valued at USD 816.77 million in 2021, and it would grow upto USD 1161.53 million by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Anxiolytics is also termed as anti-panic drugs as well as anti-anxiety agents, these are the class of CNS therapeutics that are widely used to concomitant relief from the anxiety attacks by stimulating the activity of gamma-aminobutyric acid in the brain.
Anxiolytics Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Indication (Anxiety, Insomnia, Panic Disorder, Others), Drug Class (Benzodiazepines, Azapirones, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Johnsons & Johnsons Services Inc (U.S.), Boehringer Ingelheim International GmbH (Germany.), Sun Pharmaceutical Industries Ltd. (India), Sanofi (France), AstraZeneca (U.K.), GlaxoSmithKline Plc. (U.K.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Amneal Pharmaceuticals LLC. (U.S.), Alvogen (U.S)
|
|
Market Opportunities
|
|
Global Anxiolytics Market Dynamics
Drivers
- Increasing Demand For Novel Therapies
The increasing prevalence of anxiety and depression around the world has boosted the medical researchers to produce novel treatments for maintaining mental health. For instance, Janssen CarePath’s esketamine, a nasal spray formulation of ketamine called SPRAVATO, was cleared and approved by the US FDA for the treatment for mood-related conditions such as anxiety issues, post-traumatic stress disorder (PTSD), and depression.
- Rising Demand for Oral Drugs
Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.
Opportunities
- Increased Clinical Studies and Government Initiatives
Rising awareness about the drugs and studies that are conducted for development in identifying the harmful compositions for the body that by government and private companies for better knowledge of these drugs and antidotes is likely to drive the market growth.
- Increasing Demand for Retail Pharmacies
The rise in the number of narcotic drugs delivered through retail pharmacies and the surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.
Restraints/Challenges
- Lack of skilled professionals
The lack of qualified personnel who are unable to treat the patients with these agents could curb the growth of the global anxiolytics market over a forecast period.
- High Cost
The huge expenditure associated with these agents surely hamper the market growth.
This anxiolytics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the anxiolytics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Anxiolytics Market
Considering the present scenario, COVID-19 has left an unprecedented global public health crisis that has impacted practically every business. Its long-term repercussions are expected to influence industry growth during the forecast period. Transition of healthcare infrastructure toward managing COVID-19 has led to drug launch cancellations and delays in clinical trials.
In the post-pandemic era, changes are witnessed in drug use patterns such as increase in the use of cannabis and the non-medical use of pharmaceutical sedatives. The socioeconomic stressors have also boosted the demand for these drugs. Thus, this will leave a significant impact on the narcotic drugs market.
Global Anxiolytics Market Scope
The anxiolytics market is segmented on the basis of indication, drug class, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Indication
- Anxiety
- Insomnia
- Panic Disorder
- Others
Drug Class
- Benzodiazepines
- Azapirones
- Others
Route of Administration
- Oral
- Parenteral
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Anxiolytics Market Regional Analysis/Insights
The anxiolytics market is analysed and market size insights and trends are provided by indication, drug, route of administration , distribution channel and end-user as referenced above.
The major countries covered in the anxiolytics market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America has been witnessing a positive growth for anxiolytics market throughout the forecasted period due to the global leaders in research and development activities, established framework of approval process and increase in number of FDA approval drugs.
Asia-Pacific dominates the market due to the developing healthcare facilities, large number of generic manufacturer and rise in government initiatives and specialist communities.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Anxiolytics Market Share Analysis
The anxiolytics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to anxiolytics market
Key players operating in the anxiolytics market include:
- Johnsons & Johnsons Services Inc (U.S.)
- Boehringer Ingelheim International GmbH (Germany)
- Sun Pharmaceutical Industries Ltd. (India)
- Sanofi (France)
- AstraZeneca (U.K.)
- GlaxoSmithKline Plc. (U.K.)
- Novartis AG (Switzerland)
- Pfizer Inc. (U.S.)
- Amneal Pharmaceuticals LLC. (U.S.)
- Alvogen (U.S)
SKU-